Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.0073
-0.001792 (-19.71%)
At close: Sep 4, 2026

Nascent Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
1162149
Market Cap Growth
-50.39%-85.56%-72.61%430.37%-57.01%-69.99%
Enterprise Value
-1823331114
Last Close Price
0.010.031.307.509.7558.05

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Forward PE
-7.007.00---
PS Ratio
1.020.390.864.562.323.99
PB Ratio
-0.11-0.832.133.742.681.38

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-8.263.407.126.496.23

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.92-9.163.461.301.410.02
Net Debt / Equity Ratio
-0.92-9.133.431.221.100.01
Net Debt / EBITDA Ratio
-1.33-1.50-0.73-0.70-0.24-0.01
Net Debt / FCF Ratio
36.54-6.93-2.35-0.85-0.81-0.02
Asset Turnover
0.140.170.420.450.310.42
Inventory Turnover
2.470.991.781.110.491.37
Quick Ratio
0.120.340.540.431.112.57
Current Ratio
0.140.480.700.701.276.70
Return on Equity (ROE)
--1148.32%-358.87%-343.02%-218.54%-116.40%
Return on Assets (ROA)
-62.52%-36.43%-55.28%-62.95%-84.68%-67.52%
Return on Capital Employed (ROCE)
76.30%747.20%-451.80%-146.40%-446.90%-87.80%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-1253.49%-1172.96%-259.58%-57.98%-224.36%-64.10%
FCF Yield
23.30%-158.94%-68.66%-38.14%-50.47%-38.22%
Buyback Yield / Dilution
-608.91%-252.66%-165.79%-470.01%-71.71%-45.69%